Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
UPB · NASDAQ · Pharmaceutical Preparations
$1.59−0.41 (−20.50%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Upstream Bio (UPB) · oqro.io/stocks/UPB · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Oct 29, 2026
Decheng Capital Global Life Sciences Fund IV, L.P. cut its UPB stake below 5% (4.9%)SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 18, 2026
Altshuler Shaham Ltd disclosed a reduced position in UPB for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Siren, L.L.C. no longer reported UPB for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Altshuler Shaham Ltd disclosed a reduced position in UPB for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Siren, L.L.C. disclosed a reduced position in UPB for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Deep Track Capital, LP no longer reported UPB for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 13, 2025
Altshuler Shaham Ltd disclosed a reduced position in UPB for Q3 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Deep Track Capital, LP disclosed a reduced position in UPB for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Altshuler Shaham Ltd disclosed an increased position in UPB for Q2 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 23, 2025
Siren, L.L.C. disclosed a reduced position in UPB for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Soros Fund Management no longer reported UPB for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Deep Track Capital, LP disclosed an increased position in UPB for Q1 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Soros Fund Management disclosed a new position in UPB for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Orbimed Advisors LLC disclosed a new position in UPB for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Deep Track Capital, LP disclosed a new position in UPB for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Siren, L.L.C. disclosed a new position in UPB for Q4 2024Insider trade · Traded Oct 15, 2024 · Filed Oct 17, 2024
Director purchased ~$11.2M of UPB shares in the open marketSourceInsider trade · Traded Oct 15, 2024 · Filed Oct 17, 2024
Director purchased ~$2.81M of UPB shares in the open marketSourceInsider trade · Traded Oct 15, 2024 · Filed Oct 17, 2024
10% owner purchased ~$20M of UPB shares in the open marketSourceInsider trade · Traded Oct 15, 2024 · Filed Oct 17, 2024
Director purchased ~$11.2M of UPB shares in the open marketSourceInsider trade · Traded Oct 15, 2024 · Filed Oct 17, 2024
Director purchased ~$2.81M of UPB shares in the open marketSource